About InspireMD
InspireMD is a company based in Boston (United States) founded in 2005.. InspireMD has raised $33.99 million across 14 funding rounds from investors including Hercules Capital, Marshall Wace and Orbimed. The company has 86 employees as of December 31, 2024. InspireMD offers products and services including CGuard Carotid Stent System. InspireMD operates in a competitive market with competitors including SMT, Endospan, Vesper Medical, Veryan Medical and Biosensors International, among others.
- Headquarter Boston, United States
- Employees 86 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Inspiremd Inc.
-
Annual Revenue
$7.01 M12.96as on Dec 31, 2024
-
Net Profit
$-32.01 M-60.7as on Dec 31, 2024
-
EBITDA
$-32.93 M-59.43as on Dec 31, 2024
-
Total Equity Funding
$33.99 M (USD)
in 14 rounds
-
Latest Funding Round
$40.1 M (USD), Post-IPO
Jul 31, 2025
-
Investors
Hercules Capital
& 2 more
-
Employee Count
86
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of InspireMD
InspireMD is a publicly listed company on the NASDAQ with ticker symbol NSPR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of InspireMD
InspireMD offers a comprehensive portfolio of products and services, including CGuard Carotid Stent System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Prevents strokes by trapping plaque during carotid artery procedures.
Unlock access to complete
Unlock access to complete
Funding Insights of InspireMD
InspireMD has successfully raised a total of $33.99M across 14 strategic funding rounds. The most recent funding activity was a Post-IPO round of $40.1 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Post-IPO — $40.1M
-
First Round
First Round
(05 Aug 2010)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Post-IPO - InspireMD | Valuation | Orbimed , Marshall Wace |
|
| May, 2023 | Amount | Post-IPO - InspireMD | Valuation |
investors |
|
| Dec, 2017 | Amount | Post-IPO - InspireMD | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in InspireMD
InspireMD has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Hercules Capital, Marshall Wace and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt financing is provided to companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Long-short equity strategies are managed through specialized hedge funds.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by InspireMD
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InspireMD
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Inspiremd Comparisons
Competitors of InspireMD
InspireMD operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SMT, Endospan, Vesper Medical, Veryan Medical and Biosensors International, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
SMT is recognized as a developer of cardiovascular medical devices.
|
|
| domain | founded_year | HQ Location |
Endovascular stent graft systems for aortic aneurysm repair are developed.
|
|
| domain | founded_year | HQ Location |
Venous stent system is developed for deep vein disease treatment.
|
|
| domain | founded_year | HQ Location |
Three-dimensional vascular stents for peripheral vascular disease are developed.
|
|
| domain | founded_year | HQ Location |
Products for interventional cardiology and critical care procedures
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Inspiremd
Frequently Asked Questions about InspireMD
When was InspireMD founded?
InspireMD was founded in 2005 and raised its 1st funding round 5 years after it was founded.
Where is InspireMD located?
InspireMD is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of InspireMD?
James Barry is the current CEO of InspireMD.
Is InspireMD a funded company?
InspireMD is a funded company, having raised a total of $33.99M across 14 funding rounds to date. The company's 1st funding round was a Post-IPO of $750K, raised on Aug 05, 2010.
How many employees does InspireMD have?
As of Dec 31, 2024, the latest employee count at InspireMD is 86.
What is the annual revenue of InspireMD?
Annual revenue of InspireMD is $7.01M as on Dec 31, 2024.
What does InspireMD do?
Founded in 2005 and headquartered in Boston, United States, InspireMD operates in the medical device sector, focusing on cardiovascular technologies. Proprietary stent systems, including the MicroNet mesh integrated into products like CGuard and MGuard, are developed for embolic protection during procedures such as percutaneous coronary intervention. Indications cover acute myocardial infarction, unstable angina, and carotid revascularization in high-risk patients. Commercialization targets global markets for coronary and carotid artery applications.
Who are the top competitors of InspireMD?
InspireMD's top competitors include SMT, Endospan and Vesper Medical.
What products or services does InspireMD offer?
InspireMD offers CGuard Carotid Stent System.
Is InspireMD publicly traded?
Yes, InspireMD is publicly traded on NASDAQ under the ticker symbol NSPR.
Who are InspireMD's investors?
InspireMD has 3 investors. Key investors include Hercules Capital, Marshall Wace, and Orbimed.
What is InspireMD's ticker symbol?
The ticker symbol of InspireMD is NSPR on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.